Evid Invest
Who owns ZNTLWhat ZNTL owns — n/a

Who owns Zentalis Pharmaceuticals, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ZNTL from SEC Form 13F filings across 126 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 126 institutions disclosed 60.5M shares of Zentalis Pharmaceuticals, Inc. worth $167.3M — about 71.5% of shares outstanding; the largest disclosed holder is Squadron Capital Management LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

126

13F holders

$167.3M

value, 2026 filers

71.5%

of shares outstanding (60.5M sh)

26

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ZNTL's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Squadron Capital Management LLC6.8M$18.9M4.7%8.1%+84.5%
2CITADEL ADVISORS LLC4.5M$12.4M0.0%5.3%+95.3%
35AM Venture Management, LLC3.9M$10.9M3.7%4.7%0.0%
4BlackRock, Inc.3.9M$10.8M0.0%4.6%+4.2%
5VANGUARD CAPITAL MANAGEMENT LLC3.5M$9.8M0.0%4.2%+24.3%
6ACADIAN ASSET MANAGEMENT LLC3.1M$8.5M0.0%3.6%+14.0%
7TWO SIGMA INVESTMENTS, LP2.8M$7.8M0.0%3.3%-7.4%
8Patient Square Capital LPNEW2.0M$5.6M0.9%2.4%new
9Seven Fleet Capital Management LP1.5M$4.2M0.8%1.8%+373.6%
10RENAISSANCE TECHNOLOGIES LLC1.5M$4.2M0.0%1.8%-6.9%
11Opaleye Management Inc.1.4M$3.9M0.4%1.7%0.0%
12Decheng Capital LLC1.3M$3.7M0.5%1.6%0.0%
13ORBIMED ADVISORS LLC1.3M$3.6M0.1%1.6%-5.4%
14GEODE CAPITAL MANAGEMENT, LLC1.3M$3.6M0.0%1.5%+0.2%
15VANGUARD PORTFOLIO MANAGEMENT LLC1.3M$3.5M0.0%1.5%+57.3%
16Qube Research & Technologies Ltd1.1M$3.1M0.0%1.3%+97.5%
17STATE STREET CORP1.1M$3.1M0.0%1.3%+25.1%
18BANK OF AMERICA CORP /DE/1.1M$3.1M0.0%1.3%-0.9%
19Ishara Investments LP1.1M$3.0M2.5%1.3%+5.4%
20Boxer Capital Management, LLCNEW1.0M$2.8M0.2%1.2%new
21PRIMECAP MANAGEMENT CO/CA/957,420$2.7M0.0%1.1%0.0%
22Pfizer Inc953,834$2.6M1.6%1.1%0.0%
23JPMORGAN CHASE & CO951,147$2.6M0.0%1.1%+4138.8%
24AMERIPRISE FINANCIAL INCNEW770,397$2.1M0.0%0.9%new
25Soleus Capital Management, L.P.706,280$2.0M0.1%0.8%-25.7%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.